Youngsoo Kim

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 25(Granted Patents)

Location History:

Carlsbad, CA (US) (2015 - 2021)
San Diego, CA (US) (2009 - 2024)

Company Filing History:

8 out of 270

Ionis Pharmaceuticals, Inc.

patents

5 out of 1,035

Isis Pharmaceuticals, Inc.

patents

1 out of 5

Lonis Pharmaceuticals, Inc.

patents

Years Active: 2009-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12157890 - Modulators of MALAT1 expression (2024-12-03),

2. 12042510 - Modulators of IRF4 expression (2024-07-23),

3. 11365416 - Modulators of EZH2 expression (2022-06-21),

4. 11279932 - Modulators of MALAT1 expression (2022-03-22),

5. 11241451 - Modulators of IRF4 expression (2022-02-08),

6. 11214803 - Modulators of YAP1 expression (2022-01-04),

7. RE48461 - Modulation of androgen receptor expression (2021-03-08),

8. 10479993 - Modulation of signal transducer and activator of transcription 3 (STAT3) expression (2019-11-19),

9. 9567588 - Modulation of androgen receptor expression (2017-02-14),

10. 9359608 - Modulation of signal transducer and activator of transcription 3 (STAT3) expression (2016-06-07),

11. 9175291 - Modulation of androgen receptor expression (2015-11-03),

12. 8816056 - Modulation of signal transducer and activator of transcription 3 (STAT3)expression (2014-08-26),

13. 7799764 - Modulation of HIF1-beta expression (2010-09-21),

14. 7618947 - Modulation of HIF-1 beta expression (2009-11-17),

Title: Biography of Inventor Youngsoo Kim

Introduction: Youngsoo Kim is a prominent inventor based in San Diego, CA (US), known for his significant contributions to the field of biotechnology. He holds a total of 13 patents, showcasing his innovative approach to addressing complex medical challenges.

Latest Patents: Among his latest patents are "Modulators of MALAT1 expression," which provide methods, compounds, and compositions useful for inhibiting MALAT1 expression, potentially aiding in the treatment, prevention, or amelioration of cancers associated with MALAT1. Another notable patent is "Modulators of IRF4 expression," which offers methods, compounds, and compositions for inhibiting IRF4 expression, with implications for treating cancers linked to IRF4.

Career Highlights: Youngsoo Kim has worked with leading companies in the biotechnology sector, including Ionis Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. His work has been instrumental in advancing therapeutic strategies in cancer treatment.

Collaborations: Throughout his career, Youngsoo has collaborated with esteemed colleagues, including Susan M. Freier and Robert A. MacLeod. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion: Youngsoo Kim's contributions to biotechnology and his extensive patent portfolio underscore his role as a leading inventor in the field. His work continues to impact cancer research and treatment, reflecting his

This text is generated by artificial intelligence and may not be accurate.